AzTrials
AzTrials

Palliative Care, Health ServicesPCDNCT07313748

Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for the Elderly.

An observational study of Palliative Care, Health Services, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 2 sites in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this observational, point-prevalence study is to assess the burden of palliative care needs among adults hospitalised in Internal Medicine and Geriatrics wards, and among residents of long-term care facilities, on the National Palliative Care Day (11 November). Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Palliative Care, Health Services
How many people
3,000 participants
Where
2 sitesItaly
Study dates
1 Nov 2025to 30 Jun 2026
How long will I take part?
1 Day
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population consists of adults (≥18 years) hospitalised in Internal Medicine and Geriatrics wards, as well as residents of participating long-term care facilities for older adults (RSA Medicalizzata, R2, R2D, R3) on 11 November, the National Palliative Care Day. Participants represent a heterogeneous group of medically complex individuals, typically characterised by multimorbidity, functional impairment, advanced age, and a high burden of chronic disease. All eligible patients and residents present on the day of assessment will be considered for inclusion, provided informed consent can be obtained directly or with the support of a caregiver or legal proxy.

Who may be able to join

  • Age ≥ 18 years
  • Admitted to participating Internal Medicine or Geriatrics wards or resident in participating long-term care facilities for older adults (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November (National Palliative Care Day)
  • Able to provide: written informed consent for study participation and data processing, or oral consent supported by a relative/caregiver/legal proxy

Who cannot join

  • Inability to provide written informed consent and absence of a relative/caregiver/legal proxy able to support oral consent for participation and data processing

Trial locations and contacts

2 sites in 1 country.

Italy2 sites
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, Rome, 00168

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Roma, 00168

Other trials in Italy

About this study

Official title: Palliative Care Day: Point Prevalence Survey of Palliative Care Needs in Hospitals and Residential Care Facilities for the Elderly.

The goal of this observational, point-prevalence study is to assess the burden of palliative care needs among adults hospitalised in Internal Medicine and Geriatrics wards, and among residents of long-term care facilities, on the National Palliative Care Day (11 November). The main question it aims to answer is: What is the prevalence of unmet palliative care needs in hospital and long-term care settings on 11 November? Participants (patients and residents) will be evaluated through a structured, web-based questionnaire designed for this study. The survey will collect clinical, functional, and symptom-related data- including comorbidities, mobility, nutritional status, dysphagia, pressure ulcers, indicators of palliative care needs (NECPAL), pain assessment, and delirium screening (4AT)-to produce a detailed snapshot of palliative care needs across settings.

Read the detailed description

The National Palliative Care Day, held annually on 11 November, provides a unique opportunity to assess the prevalence of palliative care needs among patients in hospitals and residents of long-term care facilities. Beyond raising awareness of palliative care, this occasion supports more accurate monitoring of patients with unmet palliative needs and enables the collection of concrete data on current care provision.

This study aims to measure the prevalence of palliative care needs among adults admitted to Internal Medicine and Geriatrics wards and among residents of participating long-term care facilities on 11 November. Assessment will be performed using a purpose-designed questionnaire. The study intends to: (1) generate a detailed estimate of palliative care needs in hospital and residential settings; (2) increase awareness among healthcare professionals and promote timely identification and management of palliative care needs; and (3) highlight the relevance of a palliative approach not only in traditional palliative care services (hospice, home-based palliative care) but also within hospitals and long-term care facilities.

A point-prevalence (cross-sectional) design will be used through administration of a web-based survey.

Sample

Inclusion criteria

Participants must meet all of the following:

  • age ≥18 years;
  • hospitalised in participating wards or residing in participating long-term care facilities (medicalised nursing homes: RSA Medicalizzata, R2, R2D, R3) on 11 November;
  • able to provide written informed consent and consent for data processing, or oral consent supported by a relative, caregiver, or proxy.

Exclusion criteria Participants will be excluded if they are unable to provide written consent or supported oral consent for participation and data processing.

Questionnaire

Palliative care needs will be assessed using a dedicated questionnaire (Appendix 1), delivered via a web platform. The instrument comprises three sections:

Facility-level data:

  • region;
  • ward type (Internal Medicine, Geriatrics) or care model for long-term facilities;
  • number of beds and number of eligible patients;
  • availability of an in-house palliative care service (hospitals) or access to specialist palliative consultation (long-term care).

Rater characteristics:

  • socio-demographic data (age group, sex);
  • profession, years of experience, current or completed specialty training.

Patient-level data:

  • socio-demographic variables (age, sex);
  • comorbidities (Charlson Comorbidity Index);
  • mobility (baseline and current functional status);
  • daily nutritional intake and recent decline;
  • dysphagia (presence and type);
  • pressure ulcers (including stage III-IV lesions);
  • palliative care indicators (NECPAL);
  • pain assessment (Numeric Pain Rating Scale, or PAINAD for advanced dementia);
  • delirium screening (4AT).
Keywords
PALLIATIVE CARE, unmet needs, HOSPITAL, LONG-TERM RESIDENCE

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence

    Prevalence of palliative care needs

    Measured: 1 DAY

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2026
  2. Study start1 Nov 2025
  3. Primary completion11 Nov 2025
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
3,000 participants (estimated)
Target duration
1 Day
IDs, dates and publications
ClinicalTrials.gov ID
NCT07313748
Sponsor's protocol ID
8190
Acronym
PCD
Status last verified
Nov 2025
First submitted
21 Nov 2025
Last updated
2 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Palliative Care, Health Services, run by Fondazione Policlinico Universitario Agostino Gemelli IRCCS at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 2 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence (time frame: 1 DAY). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in